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A B S T R A C T
Volatile organic compounds (VOCs) emitted by a human body form a chemical signature capable of pro-
viding invaluable information on the physiological status of an individual and, thereby, serving as signs
of life for detecting victims after natural or man-made disasters. For this review, we created a database
of potential biomarkers of human presence based on literature reports on VOCs in human breath, skin
emanations, blood and urine. We estimated approximate ﬂuxes of these VOCs from the human body,
and used them to predict concentrations in the vicinity of victims. We classiﬁed proposed markers in
groups by potential for victim detection. The major classiﬁcation discriminants were the capability of
detection by portable, real-time analytical instruments and background levels of VOCs in the urban en-
vironment. We intend data summarized in this review to assist studies on the detection of humans via
chemical analysis and to accelerate investigations in this area of knowledge.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Earthquakes belong to the most frequent and most catastroph-
ic natural disasters affecting mankind. In the past century,
earthquakes occurred with an annual worldwide incidence of one
million events (two earthquakes per minute) [1] causing more than
1.5 million deaths and affecting another 2 billion people [2]. Bearing
in mind the increase of global urbanization and that the most pop-
ulous cities are located in seismic zones, it is reasonable to assume
that these numbers will rise considerably in the near future [3]. In
contrast to many other disasters, earthquakes cause not only many
deaths, but also many traumatic injuries and massive entrapment
of survivors in collapsed buildings [1,3,4]. While about half the sur-
vivors are found and rescued quickly by bystanders or other civilians
[5,6], the remaining survivors are subjected to prolonged entrap-
ment under complex debris. Their extrication frequently requires
* Corresponding author. Tel.: +43 512 504 24636; Fax: +43 512 504 6724636.
E-mail address: pawel.mochalski@uibk.ac.at (P. Mochalski).
http://dx.doi.org/10.1016/j.trac.2015.02.013
0165-9936/© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
Trends in Analytical Chemistry 68 (2015) 88–106
Contents lists available at ScienceDirect
Trends in Analytical Chemistry
journal homepage: www.elsevier.com/ locate / t rac
trained, specially equipped rescuers. Since the survivability of victims
directly relates to the entrapment time [1], the early location of en-
trapped victims is of the utmost importance for urban search and
rescue (USaR) operations.
Until now, a number of technical tools have been employed to
reduce the duration of entrapment (e.g., ﬁber-optic cameras
(borescopes), acoustic probes aiming at voices, or heartbeats, thermal
cameras, and sonars) [5]. Nevertheless, SaR dogs remain indispens-
able for rescue teams and are commonly recognized as gold standard
in this context [7]. Search dogs exhibit excellent scenting skills, are
able to search relatively large areas in a short period of time and
can work in areas that are deemed unsafe or inaccessible to human
rescuers. However, dogs exhibit a number of limitations. Their
working time is relatively short and restricted to approximately
30 min (with a subsequent break of 2 h) and their training is time
consuming and expensive. Moreover, they respond poorly to being
stressed or frustrated and can easily be injured in highly toxic, harsh
disaster environments [8]. All these constraints create a huge demand
for novel detecting tools, which could complement, or even replace,
search dogs during USaR operations.
The fact that SaR dogs can detect survivors in highly contami-
nated disaster sites implies that there is a human-speciﬁc chemical
signature in void spaces of collapsed buildings and that analysis of
this signature could be a valuable detection tool. Unexpectedly, this
approach has received little attention and was limited to carbon-
dioxide sensing [9]. This is surprising as small-molecule volatile
species are often the ﬁnal products of vital metabolic pathways oc-
curring in human organisms and could therefore serve as signs of
life in the context of rescue operations [10–12]. Indeed, there is
growing evidence suggesting that some constituents of the human
scent could be employed for this purpose and thereby consider-
ably improve the effectiveness of rescue teams [13–16]. Apart from
detecting victims, chemical analysis could provide the rescuers with
the capability to recognize exposures to potentially toxic agents that
can be present at disaster sites [17,18]. Consequently, toxicologi-
cal hazards and risks for humans and animals could be considerably
minimized during rescue operations. Thus, in the context of USaR
operations, chemical analysis towards volatiles can be considered
a very promising ﬁeld, which is, however, still in its infancy.
The primary goal of this review is creation of a database con-
taining constituents of the human scent having potential to serve
as signs of life during USaR operations. The database is built on the
basis of existing literature reports on volatiles in breath, blood, urine
and skin emanations. We stress that only quantitative data are taken
into consideration. In particular, by this, we intend to provide a list
of preliminary markers of human presence to be veriﬁed and
complemented during future ﬁeld studies. An effort is also made
to estimate the approximate emission rates of these compounds from
the human body as paramount factors determining their levels in
the vicinity of survivors. Secondary goals are to predict tentative
levels of the preselected markers in void spaces of collapsed build-
ings and to assess the capabilities of their detection by selected
portable ﬁeld analytical instruments against the urban environ-
mental background.
2. Sources of human scent during entrapment
Volatile species forming human scent during entrapment can
stem from different biological ﬂuids (breath, urine, blood, sweat)
and organs (skin, lungs, bowels). Generally, sources of human-
related volatiles can be classiﬁed into continuous and temporal. The
former group embracing breath and skin emanations is particular-
ly important in the context of victim detection, as it offers a long-
lasting emission of potential markers of human presence. Moreover,
breath holds here a distinguished status, since the breath-borne
volatile species can help to differentiate between living and dead
victims.
Temporal sources, such as blood or urine, have a more tran-
sient contribution to human scent; nevertheless, this impulse-
type contribution cannot be neglected. The occurrence of this
impulse of volatiles is diﬃcult to predict; however, it is reason-
able to assume that emission of blood-borne species should appear
at the early stage of entrapment as a result of injuries induced by
the disaster. Furthermore, urine- and blood-borne compounds are
expected to strengthen the location signal provided by breath
markers of human presence due to the physiological dependen-
cies between these ﬂuids. However, blood and urine should be
considered as limited reservoirs of species tending to dry out and/or
clot.
The emission rates of volatiles from these sources depend on the
physiological and medical status of the victim (e.g., injuries, dehy-
dration, shock, diet, history of environmental exposure, and drug
intake), conditions in the entrapment scene (e.g., conﬁned space
volume, type of collapse, temperature, humidity, and oxygen
content), and the time of entrapment. In particular, the disaster event
and the entrapment induce a number of neuroendocrine, meta-
bolic and physical responses [19], which can comprise, e.g., intense
emotional stress, physical shock, hypermetabolism (manifested by
hyperglycemia, hyperlactatemia, and protein catabolism), immu-
nological responses, and up-regulation of hormone secretion. All
these factors inevitably inﬂuence the production and the emis-
sion of volatiles by a human organism. Unfortunately, this impact
is poorly understood because of the limited quantitative data on the
emission rates of volatile organic compounds (VOCs) from the human
body, limited knowledge of human physiology during entrap-
ment, and ethical and methodological problems related to the
simulation of entrapment under laboratory conditions. As a con-
sequence, the emission of volatiles from entrapped individuals and
their propagation during entrapment are very diﬃcult to esti-
mate. In this context, emission rates of volatile species from healthy
volunteers at normal conditions seem to be the only reasonable sur-
rogate for these parameters. Moreover, understanding the production
and the initial composition of the human-speciﬁc chemical signa-
ture is particularly important for modeling the behavior of potential
markers of human presence in the surroundings of the entrapped
person and determines the selection of on-site, real-time, and hand-
held analytical instruments, which could be used for the ﬁeld
detection of entrapped victims.
One of the main goals of this work is to pre-select potential
markers of human presence and to estimate their emission rates
from the human body on the basis on existing literature data on
volatile organic and inorganic compounds in breath, urine, blood,
and skin emanations. Several prerequisites have been assumed to
achieve this goal. First, only emissions via breath and skin are used
to calculate the total ﬂuxes of volatiles from the human body, because
the occurrence and the intensity of urine- or blood-borne VOCs is
much more variable and diﬃcult to predict. Second, only omni-
present and reliably identiﬁed compounds are used to construct the
set of potential markers of human presence. Here, a compound is
recognized as omnipresent when it is reported to have an inci-
dence of at least 80%. The threshold of 80% was arbitrarily chosen.
Reliable identiﬁcation is deﬁned as identiﬁcation based on several
methods, thereby providing unequivocal results. For example, in gas
chromatography mass spectrometry (GC-MS) studies, compounds
identiﬁed exclusively on the basis of a spectral library match (e.g.,
NIST) without taking into account the retention time (or retention
index) are excluded, as only tentatively identiﬁed. Finally, only species
having clearly higher levels in breath than in room air are recog-
nized as produced by the human body and thereby contributing to
the formation of human scent. We also stress that compounds are
not pre-selected with respect to their origin as it still has not been
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elucidated in suﬃcient depth and, in many cases, is a matter in
dispute. Table 1 lists volatile organic and inorganic compounds, which
fulﬁl these requirements. We tried to provide for each compound
data from different literature sources and obtained by different an-
alytical techniques to improve the reliability of calculated ﬂuxes.
2.1. Breath
Exhaled breath contains a wide range of volatile compounds
capable of providing invaluable information on normal and disease
processes occurring in an individual, environmental exposure to
pollutants/toxins, or microorganism activity in the body [10–12].
Its attractiveness in biomedical applications stems from it being
readily and non-invasively obtainable and may be sampled as often
as desirable without discomfort for a subject. Moreover, concen-
tration levels of breath compounds can respond rapidly to changes
in human physiology and thereby provide near real-time informa-
tion on processes occurring in the body [57,92–94]. In the context
of USaR operations, breath volatiles play a fundamental role, as
breathing can be considered a sign of life and the breath-speciﬁc
species can help to distinguish the living from the dead. For these
reasons, breath volatiles received enormous attention in the liter-
ature. Moreover, most published clinical studies also provide data
obtained for control populations (e.g., healthy volunteers, and hos-
pital personnel), which could be useful for this work. Unfortunately,
a considerable fraction of the existing sources suffers from disad-
vantages, such as reporting only qualitative or semi-qualitative data
(e.g., peak areas, and relative abundances), absence of detection fre-
quencies of observed species, or absence of data on room air (inhaled
air). Consequently, their value for this work is limited. Moreover,
literature sources were constrained to those providing data for the
end-tidal exhalation phase andmean concentrations of species under
scrutiny. This approach aimed to reduce the variability of results
induced by different sampling protocols.
Table 1 lists 34 breath volatiles selected using these criteria to-
getherwith their literature levels in the end-tidal exhalation segment.
These concentration data were used to calculate the breath ﬂuxes
of compounds of interest. First, for each compound, a weighted ar-
ithmetic mean of means was calculated using all literature sources
considered. The weight factor was the population involved in the
particular study. Next, these means were converted into nmol × L−1.
Finally, the emission rates expressed in nmol × min−1 × person−1 were
calculated, assuming alveolar ventilation of 3.3 L × min−1, which is
typical for sleep [95], because entrapped victims are frequently un-
conscious, or drift between sleep and consciousness over the course
of entrapment [5]. Since the real values of alveolar ventilation during
entrapment are diﬃcult to predict and can be considerably affect-
ed by the conditions in the entrapment environment, sleep seems
to be a good (although simpliﬁed) surrogatemodel. Table 1 and Fig. 1
show the calculated breath ﬂuxes of compounds of interest.
With the exception of CO2, the estimated emission rates are
0.03–524 nmol × min−1 × person−1. Within this group, the highest
values were for CO (524 nmol × min−1 × person−1), ammonia
(91 nmol × min−1 × person−1), acetone (60 nmol × min−1 × person−1),
and methanol (45 nmol × min−1 × person−1). The majority of com-
pounds (56%) exhibited breath ﬂuxes below 1 nmol ×min−1 × person−1
(considering means).
2.2. Skin
Skin, next to breath, is a principal source of human-scent con-
stituents, as it offers a long-lasting emission of VOCs from a relatively
large area. The composition of skin emanations in humans has re-
ceived considerable attention and numerous reports dealing with
this issue can be found in the literature [20,51,96–98]. Although these
studies reported a large number of species, the majority of them
yield only qualitative data (i.e., names of identiﬁed compounds and
possibly their occurrence in skin emanations). Moreover, the
GC-MS-based studies providemainly tentative identiﬁcation of these
species based on peak spectra that were checked against commer-
cial mass spectral libraries (e.g., NIST). Quantitative data (emission
rates) are relatively sparse [25,32,33,43,51–53] and usually deter-
mined for peripheral skin (hand, arm, or leg). Such a sampling
protocol is obviously convenient for human subjects; however, the
Fig. 1. Ranges and means of emission rates of potential breath markers of human presence from the human body. Different colors correspond to the different chemical
classes of compounds. Ranges calculated on the basis of reports indicated in column B of Table 1.
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Table 1
Breath concentrations, skin emissions, tentative origins and whole body ﬂuxes of potential volatile markers of human presence. Urine and blood omnipresent species taken from [16,20–22]
A B C D E F G H I
Compound CAS Breath levels mean
(population) [ppb]
Skin emission mean
(population)
Urine Blood Tentative origin in humans Fluxbreath
[nmol/min]
Fluxskin
[nmol/min]
Fluxtotal
[nmol/min]
CO2
124-38-9
(a) 4.9 % (19) [23]
(b) 6.1 % (6) [24]
(a) 3.4 × 10−5ml × cm−2 × min−1 (63) arm/hand [25] ● (a) Cellular respiration 66.8 × 105 26.5 × 103 67.1 × 105
NO
10102-43-9
(c) 7.8 (294) [26]
(d) 7.2 (20) [27]
(e) 8.2 (10) [28]
(f) 27.6 (106) [29]
(g) 18.9 (26) [30]
(h) 17.5 (89) [31]
(b) 12.8 fmol × cm−2 × min−1 (14) hand [32]
(c) 79.5 fmol × cm−2 × min−1 (14) hand/arm [33]
● (a) Enzymatic oxidation of
L-arginine (iNOS) [34]
1.8 0.8 2.6
CO
630-08-0
(a) 3.2 ppm (20) [27]
(b) 2.9 ppm (37) [35]
(c) 4.3 ppm (239) [36]
(d) 3.6 ppm (55) [37]
(e) 4.1 ppm (857) [38]
● (a) Hemoprotein turnover [39] 524.5 524.5
Ammonia
7664-41-7
(a) 1015 (5) [40]
(b) 854 (17) [41]
(c) 589 (48) [42]
(d) 775 (20) [43]
(e) 480 (30) [44]
(a) 0.5 ng × cm−2 × min−1 (30) hand [43] ● ● (a) Bacterial metabolism of proteins
in gut [45]
(b) Bacterial metabolism of proteins
in oral cavity [21,46]
90.9 513.8 604.7
Acetone
67-64-1
(a) 487 (5) [40]
(b) 477 (30) [44]
(c) 456 (17) [41]
(d) 226 (143) [47]
(e) 255 (31) [48]
(f) 217 (40) [49]
(g) 950 (28) [22]
(h) 628 (215) [50]
(a) 1370 fmol × cm−2 × min−1 (31) hand [51]
(b) 44.8 nmol × person−1 × min−1 (10) body [52]
(c) 4.3 ng × cm−2 × h−1 (60) hand [53]
● ● (a) Endogenous decarboxylation of
acetyl–CoA [50]
(b) Oxidation of squalene [54]
(c) 2-propanol metabolism [55]
(d) Diet
59.8 25 84.8
2-Butanone
78–93-3
(a) 5.1 (143) [47]
(b) 0.24 (40) [49]
(c) 2.6 (28) [22]
(a) 7.2 fmol × cm−2 × min−1 (31) hand [51]
(b) 4.3 nmol × person−1 × min−1 (10) body [52]
● ● (a) Diet [56] 0.5 1.15 1.65
2-Pentanone
107-87-9
(a) 4.8 (143) [47]
(b) 0.36 (40) [49]
(c) 0.62 (28) [22]
(d) 0.22 (7) [57]
(a) 2.47 fmol × cm−2 × min−1 (31) hand [51] ● ● (a) Diet [56]
(b) 2-pentanol metabolism [58]
0.43 0.05 0.47
5-Hepten-2-one, 6-methyl-
110-93-0
(a) 212.9 fmol × cm−2 × min−1 (31)hand [51]
(b) 0.98 nmol × person−1 × min−1 (10) body [52]
(a) Cutaneous oxidation of
squalene [54]
3.08 3.08
3-Buten-2-one
78–94-4
(a) 3.8 (28) [22]
(b) 5.5 (143) [47]
(a) 9.2 fmol × cm−2 × min−1 (31) hand [51]
(b) 6.8 nmol × person−1 × min−1 (10) body [52]
(a) Oxidation of isoprene [59] 0.67 1.78 2.45
2,3 Butanedione
431-03-8
(a) 29 (28) [22] (a) Diet (butter) [56] 3.74 3.74
Acetaldehyde
75-07-0
(a) 67.4 (143) [47]
(b) 5.5 (12) [60]
(c) 24 (30) [61]
(a) 466 fmol × cm−2 × min−1 (31) hand [51]
(b) 3.8 ng × cm−2 × h−1 (60) hand [53]
● ● (a) Ethanol metabolism [62]
(b) Cutaneous oxidative degradation
of linoleic acid [63]
7.3 15.4 22.7
n-Propanal
123-38-6
(a) 18.3 (28) [22]
(b) 6.9 (143) [47]
(a) 18.4 fmol × cm−2 × min−1 (31)hand [51]
(b) 6.6 nmol × person−1 × min−1 (10) body [52]
● (a) Cutaneous of linoleic acid and
oleic acid [63]
(b) 1-propanol metabolism
(c) Diet [56]
1.13 1.85 2.98
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Table 1 (continued)
A B C D E F G H I
Compound CAS Breath levels mean
(population) [ppb]
Skin emission mean (population) Urine Blood Tentative origin in humans Fluxbreath
[nmol/min]
Fluxskin
[nmol/min]
Fluxtotal
[nmol/min]
2-Propenal
107-02-8
(a) 5.9 (28) [22] (a) 21 fmol × cm−2 × min−1 (31) hand [51] (a) Smoking [64] 0.76 0.37 1.13
2-Propenal, 2-methyl
78–85-3
(a) 1.2 (28) [22] (a) 20.5 fmol × cm−2 × min−1 (31)hand [51]
(b) 0.54 nmol × person−1 × min−1 (10) body [52]
(a) Oxidation of isoprene [59] 0.15 0.42 0.57
Propanal, 2-methyl-
78–84-2
(a) 11.6 fmol × cm−2 × min−1 (31)hand [51] ● (a) Diet [65] 0.21 0.21
Butanal, 2-methyl-
96-17-3
(a) 13.9 fmol × cm−2 × min−1 (31) hand [51] ● (a) Diet [65] 0.25 0.25
Butanal, 3-methyl-
590-86-3
(a) 15.1 fmol × cm−2 × min−1 (31)hand [51] ● (a) Diet [65] 0.28 0.28
n-Hexanal
66-25-1
(a) 15.4 (31) [48] (a) 56.2 fmol × cm−2 × min−1 (31) hand [51]
(b) 2.46 nmol × person−1 × min−1 (10) body [52]
● (a) Cutaneous degradation of linoleic,
palmitoleic and vaccenic acids [66]
2.1 1.36 3.44
n-Heptanal
111-71-7
(a) 0.07 (12) [60] (a) 29.8 fmol × cm−2 × min−1 (31) hand [51]
(b) 1.85 nmol × person−1 × min−1 (10) body [52]
● (a) Cutaneous oxidative degradation of
palmitoleic acid, vaccenic acid [66]
<0.001 0.84 0.84
n-Octanal
124-13-0
(a) 0.27 (12) [60] (a) 42.7 fmol × cm−2 × min−1 (31) hand [51]
(b) 1.3 nmol × person−1 × min−1 (10) body [52]
● (a) Oxidative degradation of oleic
acid [63]
0.04 0.88 0.92
n-Nonanal
124-19-6
(a) 0.8 [60] (a) 60.2 fmol × cm−2 × min−1 (31) hand [51]
(b) 2.16 nmol × person−1 × min−1 (10) [52]
● (a) Oxidative degradation of oleic
acid [66]
0.11 1.33 1.44
Isoprene
78–79-5
(a) 89 (5) [40]
(b) 118 (30) [67]
(c) 99.3 (205) [68]
(d) 71 (143) [47]
(e) 131 (28) [22]
(a) 4.6 fmol × cm−2 × min−1 (31) hand [51] ● ● (a) Endogenous cholesterol
synthesis [68]
(b) Peroxidation of squalene [69]
(c) Cutaneous synthesis of
squalene [70]
12.0 0.09 12.1
1,3-Pentadiene, 2-methyl-, Z-
2787-45-3
(a) 2.54 fmol × cm−2 × min−1 (31) hand [51] 0.05 0.05
1,3-Pentadiene, 2-methyl-, E-
926-54-5
(a) 1.7 fmol × cm−2 × min−1 (31) hand [51] 0.03 0.03
2-Pentene, 2-methyl-
625-27-4
(a) 12.7 fmol × cm−2 × min−1 (31)hand [51]
(b) 0.32 nmol × person−1 × min−1 (10) body [52]
(a) Peroxidation of squalene [69] 0.25 0.25
1-Heptene
592-76-7
(a) 1.73 fmol × cm−2 × min−1 (31)hand [51] 0.003 0.003
n-Heptane
142-82-5
(a) 3.3 fmol × cm−2 × min−1 (31)hand [51] (a) Cutaneous degradation of oleic
acid [63]
0.06 0.06
1-Octene
111-66-0
(a) 3.25 fmol × cm−2 × min−1 (31)hand [51] 0.06 0.06
n-Octane
111-65-9
(a) 0.12 (28) [22] (a) 8.3 fmol × cm−2 × min−1 (31) hand [51] ● (a) Oxidative degradation of oleic
acid [63]
0.02 0.15 0.17
1-Nonene
124-11-8
(a) 3.7 fmol × cm−2 × min−1 (31)hand [51] 0.06 0.06
n-Nonane
111-84-2
(a) 14.3 fmol × cm−2 × min−1 (31)hand [51] 0.26 0.26
Methanol
67-56-1
(a) 450 (30) [71]
(b) 272 (20) [72]
(c) 202 (10) [73]
(a) Emitted (no quantitative data) [74,75] ● ● (a) Bacterial metabolism of
carbohydrates in gut [76]
(b) Diet
45.1 * 45.1
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Table 1 (continued)
A B C D E F G H I
Compound CAS Breath levels mean
(population) [ppb]
Skin emission mean (population) Urine Blood Tentative origin in humans Fluxbreath
[nmol/min]
Fluxskin
[nmol/min]
Fluxtotal
[nmol/min]
Ethanol
64-17-5
(a) 86 (5) [40]
(b) 189 (143) [47]
(c) 196 (30) [61]
(d) 233 (15) [77]
(e) 165 (20) [72]
(f) 46 (15) [78]
(a) Emitted (no quantitative data) [74] ● ● (a) Gut bacterial metabolism [79]
(b) Diet
23.1 * 23.1
2-Propanol
67-63-0
(a) 22 (30) [44]
(b) 150 (46) [80]
(a) Emitted (no quantitative data) [74] (a) Diet [56]
(b) Acetone metabolism [81]
12.84 * 12.84
Dimethyl sulﬁde
75-18-3
(a) 9.3 (143) [47]
(b) 35 (50) [82]
(c) 7.3 (31) [48]
(d) 13.9 (40) [49]
(e) 5 (28) [22]
(f) 7.6 (20) [72]
(a) 2.52 fmol × cm−2 × min−1 (31) hand [51] ● ● (a) Endogenous metabolism of
sulfur-containing amino acids [83]
(b) Bacterial decomposition of
sulfur-containing amino acids [83]
1.77 0.05 1.81
Allyl methyl sulﬁde
10152-76-8
(a) 0.1 (40) [49]
(b) 1.6 (28) [22]
(a) Diet (garlic) [84] 0.09 0.09
Methyl propyl sulﬁde
3877-15-4
(a) 2.6 (28) [22] ● (a) Diet (onion) [85] 0.29 0.29
p-Cymene
99-87-6
(a) 0.14 (28) [22] (a) 4.9 fmol × cm−2 × min−1 (31) hand [51] ● (a) Diet [56] 0.018 0.075 0.094
DL-Limonene
138-86-3
(a) 1.46 (28) [22]
(b) 2.3 (20) [72]
(a) 25.6 fmol × cm−2 × min−1 (31) hand [51]
(b) 0.89 nmol × person−1 × min−1 (10) body [52]
● ● (a) Diet [56] 0.23 0.54 0.77
α-Pinene
80-56-8
(a) 0.6 (28) [22] (a) Perfumes, cosmetics 0.08 0.08
Furan, 2-methyl-
534-22-5
(a) 0.55 (28) [22]
(b) 9.5 (143) [47]
(a) 1.9 fmol × cm−2 × min−1 (31) hand [51] ● (a) Smoking [64] 1.03 0.03 1.06
Furan, 3-methyl-
930-27-8
(a) 0.18 (28) [22] (a) 1.2 fmol × cm−2 × min−1 (31) hand [51] ● ● (a) Oxidation of isoprene [59]
(b) Skin microbiota metabolism [86]
0.023 0.023 0.045
Furan, 2-pentyl-
3777-69-3
(a) 2.3 fmol × cm−2 × min−1 (31)hand [51] ● (a) Cutaneous oxidation of linoleic
acid [87]
(b) Skin microbiota metabolism [88]
0.04 0.04
Acetonitrile
75-05-8
(a) 31.5 (28) [22]
(b) 2.0 (19) [89]
(c) 5.7 (77) [90]
(a) 26.8 fmol × cm−2 × min−1 (31) hand [51] ● ● (a) Smoking [64] 1.41 0.56 1.98
γ-Butyrolactone
96-48-0
(a) 2.8 (28) [22] (a) 34.4 fmol × cm−2 × min−1 (31)hand [51] (a) Skin microbiota metabolism [91]
(b) Diet [56]
0.36 0.59 0.95
Methyl acetate
79-20-9
(a) 2.6 (28) [22]
(b) 0.98 (7) [57]
● ● 0.29 0.29
Dimethyl selenide
593-79-3
(a) 0.35 (28) [22]
(b) 0.13 (40) [49]
● (a) Selenomethionine and
selenocysteine metabolism
0.029 0.029
* No quantitative data.
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results obtained are not necessarily representative for the remain-
ing parts of the skin, because, due to the differences in the
distribution of sebaceous glands, the composition and the thick-
ness of human sebum vary between different parts of the body
[20,99] and the emission of volatiles can reﬂect these variations.
Whole-body emission data are even sparser, although the most val-
uable for this review [52], so assessment of the contribution of skin-
borne species to the formation of a human-speciﬁc chemical
ﬁngerprint may suffer from shortage of reliable data.
The skin ﬂuxes of compounds of interest from the whole human
body were estimated in several steps. First, the emission rates re-
ported for a certain skin area (e.g., cm2) were rescaled to the total
skin area of the volunteer. This was done using the skin area of the
volunteer estimated by the formula given by Mosteller [100], or (in
the case of the unavailability of the volunteer data) by taking the
average area of the human skin of 1.7 m2. Next, the emission rates
were converted into nmol × L−1 × person−1 and the weighed arith-
metic mean of the means of all literature data considered was
calculated. The weight factor was the population of the particular
study. We stress that the use of peripheral skin data for these pur-
poses implies underestimation of the calculated whole body ﬂuxes.
Table 1 and Fig. 2 show the emission rates of potential markers of
human presence obtained from skin. Their values vary from
26.5 μmol × min−1 × person−1 to 0.02 nmol × min−1 × person−1 for CO2
and 3-methylfuran, respectively. Of 38 species, only ﬁve (CO2,
ammonia, acetone, acetaldehyde, and 6-methyl-5-hepten-2-one)
exhibit ﬂuxes exceeding 2 nmol × min−1 × person−1.
2.3. Urine
Urine is an important reservoir of human-scent constituents.
Until now, more than 230 VOCs belonging to different chemical
classes (e.g., aldehydes, ketones, furans, pyrroles, terpenes, sulfur-
containing compounds) have been identiﬁed in human urine
[16,79,101–103]. This high abundance of species results from the
pre-concentration capabilities of the kidneys, so, in a certain sense,
urine offers an insight into the composition of blood volatile com-
pounds. Nevertheless, in the context of USaR operations, this source
of markers suffers from several disadvantages, such as unpredict-
able and temporal occurrence, or limited capacity. Its contribution
to the total ﬂux of volatiles from human body during entrapment
is also diﬃcult to estimate. It is reasonable to assume that the ﬂuxes
of some species (e.g., ketones) can be temporarily strengthened
[14,16] after the urinating event, but this increase of emission will
depend on their physicochemical properties. For example, com-
pounds well soluble in urine will be released for much longer than
poorly soluble ones [14]. Moreover, the entrapment conditions, such
as temperature, humidity, or dehydration, can considerably affect
the urination cycles and quantities. For these reasons, the contri-
bution of urine-borne species to the total ﬂux of VOCs has not been
assessed quantitatively within this review. Instead, we report only
their omnipresence to indicate that this source can raise the total
signal.
2.4. Blood
Apart from many deaths, earthquakes typically result in many
traumatic injuries. These injuries are highly mechanical and often
multiple. The musculoskeletal injuries typically embrace lacera-
tions, fractures, crush injuries, soft-tissue contusions, or chest trauma
[1]. Consequently, the probability of victims bleeding after the di-
saster event is relatively high. Although, the levels of volatiles in
blood are generally lower than in urine (acetone is here an excep-
tion worth mentioning), the emission of blood species is muchmore
predictable and should occur at the early stage of entrapment.
However, blood, as a source of volatiles, shares the limitations of
urine. It is temporal, of limited capacity, and its contribution to the
chemical signature is variable and depends on the medical status
Fig. 2. Ranges and means of emission rates of potential skin-borne markers of human presence from the human body. The colors correspond to the different chemical classes
of compounds. Ranges have been calculated on the basis of reports indicated in column C of Table 1.
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of the victim. Thus, as in the case of urine, Table 1 shows only the
omnipresence of blood species to stress its possible contribution.
3. Potential markers of human presence
Altogether, 47 compounds were selected as potential markers
of buried victims (see Table 1) on the basis of data on skin and breath
VOCs. Their total mean emission rates from the human body are
given in Table 1 (column I) and shown in Fig. 3. The tentative origins
of these species in human organisms have been listed in Table 1
(column F). Within this set of species, the most numerous chem-
ical classes are aldehydes (23%) and hydrocarbons (21%). Other well-
represented families are ketones (13%) and inorganic compounds
(9%).
We stress that this list should be considered an initial library to
be complemented and veriﬁed under ﬁeld conditions rather than
a closed, complete set of potential markers. In particular, a number
of omnipresent breath species were excluded due to the shortage
of quantitative data, or contradictory information on their origin.
The chemical pattern depicted in Fig. 3 demonstrates that both per-
manent sources of volatiles in humans contribute considerably to
the formation of a human-speciﬁc chemical ﬁngerprint and nu-
merous species stem from both breath and skin. This is not
surprising, as endogenously produced compounds can be distributed
actively (vascular system) or passively (diffusion) among tissues and
organs and ﬁnally released via breath, skin, or urine.
Four inorganic compounds (CO2, CO, NO, and ammonia) have been
preselected within this work. With the exception of NO, they exhibit
very high emission rates from the human body, and thereby offer
an enhanced possibility for the detection of victims in voids of col-
lapsed buildings. They are predominantly released via breath. Only
ammonia has a considerable skin-emission component.
Carbon dioxide appears to be the most natural candidate as a
sign of life. It is produced endogenously in huge amounts and re-
leased almost exclusively via breath. Its total ﬂux is approximately
four orders of magnitude higher than the ﬂux of the second most
abundant compound – ammonia. Moreover, it is relatively inert and
rapidly transportable by air currents; however, its levels can be in-
ﬂuenced by high humidity and water absorption on debris materials
[15], or ﬁres in the voids of collapsed buildings. Indeed, CO2 has
already been employed by shipping companies for detection of stow-
aways in, e.g., harbor or airport locations [9]. Despite these
advantages CO2 poses some hazards for an entrapped victim. In the
absence of air currents within the void spaces, its levels will rise
and the levels of oxygen will decrease, leading to asphyxiation and
death of victims.
Conversely, ammonia – another abundant inorganic com-
pound – seems to be releasedmainly through skin emanations. More
Fig. 3. Total emission rates (considering means) of potential volatile markers of human presence from the human body. CO2 was excluded for reasons of clarity.
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than 85% of its total ﬂux stems from this source. In healthy indi-
viduals, ammonia is produced in the gut during bacterial breakdown
of proteins [45]. However, analogous protein breakdown in the oral
cavity or on the surface of the skin may also contribute to the ﬂux
of ammonia [21]. It is unclear why ammonia exhibits such a con-
siderable skin component. Perhaps skin emission is promoted by
the rapid diffusion of NH3 via tissues resulting from the low mo-
lecular mass of this volatile. The usefulness of ammonia as an
indicator of human presence was suggested by several authors
[13,15]. Interestingly, its ﬂux seems to differ between sleep and con-
sciousness [15]. Since other species can share this phenomenon,
studies on breath VOCs during sleep are of particular importance
for USaR operations [24]. The production of CO in humans is as-
cribed to the endogenous metabolism of heme [39]. Relatively high
levels in breath (at low-ppm concentration) render CO one of the
most abundant volatiles amongst species released by humans.
A total of six ketones were found to be omnipresent in human
breath and/or skin emanations and thereby valuable for the detec-
tion of humans – acetone, 2-butanone, 2-pentanone, 3-buten-2-one,
2,3-butanedione, and 6-methyl-5-hepten-2-one. Acetone is themajor
ketone produced in the human organism, exhibiting high abun-
dances in breath [22,44,50], blood [104] and urine [16,101]. Several
sources of acetone in humans can be indicated:
(i) endogenous decarboxylation of acetyl–CoA [50,105];
(ii) oxidative degradation of squalene on human skin [54];
(iii) 2-propanol metabolism [55]; and,
(iv) diet.
However, the latter two are of minor importance. The high emis-
sion rate of 85 nmol × min−1 × person−1, endogenous production and
high volatility render acetone a very promising marker of buried
victims. Indeed, early experiments aiming at the identiﬁcation of
markers of human presence indicated acetone as a compound having
great potential [13,15]. The remaining ketones were characterized
by much lower emission rates of 0.47–3.7 nmol × min−1 × person−1.
The origin of these species remains ambiguous, so it is diﬃcult to
assess their usefulness during USaR operations. For example,
2,3 butanedione appears to originate from butter consumption;
whereas 3-buten-2-one may be a product of isoprene degrada-
tion. 6-methyl-5-hepten-2-one is an interesting ketone released from
human skin in considerable amounts. It stems from the oxidative
degradation of squalene – a major component of human sebum.
Squalene is a particularly interesting component of sebum, as its
levels are very low in other organs but particularly high in human
skin and in the range 12–20% of total skin-surface lipids [106]. This
high abundance is also unique to human skin, when compared to
other animals. Squalene is believed to be a natural antioxidant
capable of neutralizing reactive oxygen species (ROS) [99,107]. While
exposed to ROS, it degrades, producing a wide range of semi-
volatile and volatile products [69,99,108]. Some of these compounds
can thus be human speciﬁc and thereby very valuable for USaR
operations. 6-methyl-5-hepten-2-one could be a prototypic repre-
sentative of this group. Although it was found to be emitted by some
plants [54], in urban environments, it could be a biomarker of human
presence.
Aldehydes with 11 representatives were the most numerous
chemical family amongst the compounds of interest. Interest-
ingly, they predominantly originate from skin. With the exception
of acetaldehyde, 2-propenal, n-hexanal, and n-propanal, their breath
ﬂuxes are very small, frequently negligible, compared to the skin
ﬂuxes. This ample presence of aldehydes in skin emanations mirrors
the oxidative stress-inducing peroxidation of unsaturated fatty acids
on skin. Apart from squalene, sebum contains numerous long-
chain fatty acids (up to 26 carbon atoms), linear or branched,
predominantly saturated or mono-unsaturated [99,109]. Strikingly,
the fatty-acids fraction embraces unique components (e.g., branched-
chain species) or lipids with unique patterns of unsaturation
[109,110]. For example, two predominant sebum lipids, sapienic and
sebaleic acid, have not been identiﬁed in other human tissues or
the sebaceous gland secretions of other animals [106]. Oxidative
stress on the skin surface causes peroxidation of these fatty acids
with subsequent formation of numerous volatile products (alde-
hydes, ketones, hydrocarbons, alcohols, or esters) [63,66,111,112].
They are generated via β-scission of alkoxy radicals formed by the
homolytic cleavage of fatty-acid hydroperoxides. For example, ox-
idation of oleic acid leads to the release of n-octanal, n-nonanal,
n-decanal, n-heptane, and n-octane [63,66,111,112]. Interestingly,
some aldehydes are more abundant in skin emanations of older sub-
jects {e.g., n-nonanal [20], or 2-nonenal [66]}, indicating some age-
related changes in the fraction of fatty acids in skin. Bearing in mind
themultitude and diversity of fatty acids building the human sebum,
it is not surprising that skin emanations contain numerousmembers
of this chemical family. However, oxidation of fatty acids is not the
only source of aldehydes in the human organism. They can also be
products of the endogenous oxidation of primary alcohols cata-
lyzed by alcohol dehydrogenases (ADHs) [62], or stem from dietary
sources. Thus, breath acetaldehyde can mirror ethanol metabo-
lism, whereas n-propanal may reﬂect exposure to 1-propanol.
Regarding hydrocarbons, 10 species were preselected. Amongst
them, there are four alkenes, three alkanes, and three diens. Al-
though hydrocarbons emitted by the human body have received
special attention as non-invasive markers of numerous diseases or
metabolic disorders [10–12], their sources in humans have not been
elucidated in suﬃcient depth. Nevertheless, several metabolic path-
ways leading to the formation of hydrocarbons of interest can be
indicated. A wide range of hydrocarbons (both saturated and un-
saturated) is generated during cutaneous oxidation of the sebum
components, such as fatty acids and squalene. This mechanism is
identical to that responsible for the formation of aldehydes and pro-
ceeds as described above. Thus, n-octanewas found to be the product
of the oleic-acid degradation [63], whereas, 2-methyl-2-pentene was
reported to stem from decomposition of squalene [69]. Isoprene is
an unsaturated hydrocarbon produced in humans in large quanti-
ties [68]. According to the current theory, it is formed from
isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl py-
rophosphate (DMAPP) in the mevalonic acid (MVA) pathway [68].
In animals and humans, it has been suggested to be produced non-
enzymatically by acid-catalyzed formation from DMAPP occurring
in the cytosol of hepatocytes. Nevertheless, there is growing evi-
dence provided by a number of recent studies suggesting that other
endogenous metabolic sources may contribute to isoprene forma-
tion in humans [113,114].
All preselected alcohols (ethanol, methanol, and 2-propanol)
exhibit high abundances in human scent. Their total emission
rates range from 12.8 nmol × min−1 × person−1 for 2-propanol to
45.1 nmol × min−1 × person−1 for methanol. It is worth mentioning
that these species are also emitted via skin emanations in consid-
erable amounts [74]. However, due to the shortage of quantitative
data, it is diﬃcult to assess their skin-borne component in the total
ﬂux. Several sources of these compounds can be listed in humans.
First, they can stem from dietary sources (e.g., fruit consumption)
[56]. Methanol and ethanol can be produced by the bacterial ﬂora
in gut and/or oral cavity [76,115] and 2-propanol can be the product
of acetone metabolism catalyzed by ADHs [81,116,117].
Amongst sulfur-containing compounds, there were two diet-
related species (allyl methyl sulﬁde and methyl propyl sulﬁde) and
dimethyl sulﬁde (DMS). The presence of allyl methyl sulﬁde in human
tissues and ﬂuids is attributed to the garlic consumption [84];
whereas, methyl propyl sulﬁde was shown to appear in human
breath after onion intake [85]. DMS is a volatile reported to be om-
nipresent in human breath and blood [22]. Its production is ascribed
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to the metabolization of sulfur-containing amino acids methio-
nine and cysteine in the transamination pathway [83]. Thus, in liver,
thiol S-methyl transferase forms DMS via the methylation of methyl
mercaptane [83,118].
Of terpenes, DL-limonene exhibits the highest emission rate of
0.77 nmol ×min−1 × person−1. The ﬂuxes of the remaining species from
this chemical family (p-cymene and α-pinene) are notably lower
and do not exceed 0.1 nmol × min−1 × person−1. Despite their omni-
presence, the origin of these species in humans remains ambiguous.
Nevertheless, diet seems to be the most probable reason for their
occurrence [56,119].
Amongst the remaining compounds are three furans (2-
methylfuran, 3-methylfuran, and 2-pentylfuran), acetonitrile,
γ-butyrolactone, methyl acetate, and dimethyl selenide. Several com-
pounds from this set can stem from the metabolism of microbiota
inhabiting the surface of human skin. For example, fungi of the genus
Malassezia naturally found on the human skin were found to produce
an odor exhibiting high abundance of a homologous series of
γ-lactones (C8-C12) in the presence of oleic acid or human sebum
[91]. Although γ-butyrolactone could not be measured in the above
study [119], due to some analytical limitations, it appears plaus-
ible that also this compound could be a marker of fungi from this
genus. Moreover, 2-pentylfuran was demonstrated to be pro-
duced by Fusarium sp. and Aspergillus ﬂavus [88]; whereas,
3-methylfuran was found to be released by Penicillium sp. and As-
pergillus ﬂavus [86]. All these species of fungi inhabit human skin
[120]. Alternatively, 3-methylfuran might also be produced endog-
enously during the alkoxy radical-induced degradation of isoprene,
as was established in atmospheric studies [59,121]. If so, isoprene
could be considered as a ROS scavenger protecting the skin surface
from oxidative stress-induced damage. Nevertheless, additional ex-
periments are necessary to pinpoint the role of isoprene in human
physiology. Interestingly, acetonitrile, a compound commonly being
attributed to smoking habits [64], also appears in the scent of non-
smokers [89,90]. Perhaps additional endogenous sources contribute
to its presence in humans.
4. Changes in emission rates of VOCs during entrapment
Entrapment conditions and disaster-related injuries notably affect
the physiology and the biochemistry of humans [19]. Earthquakes
typically cause highly mechanical and often multiple injuries.
Amongst them musculoskeletal injuries, such as lacerations, frac-
tures, crush injuries, or spinal trauma are the most common [1].
These traumas induce numerous systemic complications and a
number of neuroendocrine, metabolic, and physical responses. The
latter can comprise, e.g., intense emotional stress, physical shock,
hypermetabolism (manifest by hyperglycemia, hyperlactatemia, and
protein catabolism), immunological responses, or up-regulation of
hormones secretion [19]. Moreover, prolonged entrapment intro-
duces additional complications (e.g. dehydration, starvation, or
asphyxiation). Although the epidemiology of disaster-related inju-
ries and complications has received considerable attention [1], little
is known about how these conditions affect the production and the
emission of volatiles from the human body in general and markers
of human presence in particular. This lack of knowledge is due to
the limited quantitative information on the emission rates of VOCs
from the human body, limited knowledge of their origin and fate,
and ethical and methodological problems related to the simula-
tion of entrapment in a laboratory environment. Nevertheless,
despite these constraints, several possible responses of the human-
speciﬁc chemical ﬁngerprint to the entrapment can be indicated.
Starvation, stress, and hypermetabolism (hyperglycemia) induce
the production of ketones in the body, which should manifest
increased emission rates of acetone [19]. Abnormally high concen-
trations of acetone (ketoacidosis), in turn, foster its biotransformation
into 2-propanol catalyzed by ADHs and thereby increase the levels
of 2-propanol in the human organism [81,116,117].
Crush injuries are usually associated with traumatic
rhabdomyolysis and release of products of muscle degradation. These
compoundsmay includemyoglobin, uric acid, potassium, lactic acid,
or creatine kinase [1]. In excess, these species have toxic effects on
distant organs. In particular, high levels of myoglobin accompa-
nied by acidosis and hypovolemia obstruct the tubular ﬂow of
kidneys and induce acute kidney injury. Impaired kidneys fail to elim-
inate urea and precipitate the rise of ammonia levels in tissues and
ﬂuids (hyperammonemia) [19].
The entrapped victim is inherently cut off from the predomi-
nant factors inducing oxidative stress on the skin surface, such as
UV radiation or O3, so we can expect that the skin production of
oxidative stress-related species will be reduced shortly after en-
trapment. In particular, this reduction can affect emission rates of
numerous aldehydes and hydrocarbons (see Table 2). Consequent-
ly, the applicability of compounds from this group may be limited
to the initial period of rescue operations.
Diet contributes enormously to the pool of VOCs in the human
organism. Myriads of volatile compounds are consumed as ﬂavor
constituents of food or beverages [56]. Some of them are of natural
origin, whereas others stem from human or bacterial food metab-
olism. These volatiles are next distributed amongst tissues and
excreted via breath, skin, or urine. A number of compounds being
potential markers of human presence can at least partly originate
from this source, as shown in Table 2. Prolonged starvation will
reduce the abundance of diet-related compounds in the speciﬁc
chemical pattern of a human. Thus, they can have limited applica-
bility during longer rescue operations. In particular, this problem
can concern some abundant species, such as methanol, ethanol, or
ammonia (produced mainly by bacteria in gut and/or oral cavity).
Thus, knowledge of the origin and the metabolic fate of potential
markers of human presence is of utmost importance for their
veriﬁcation.
5. Human-speciﬁc chemical signature at the entrapment site
Once emitted, volatiles forming the human scent are spread by
air currents throughout the void spaces of collapsed buildings, in-
teract with debris materials, and mix with environmental and
disaster-related contaminants and/or toxic agents. All these factors
can considerably distort the original human-speciﬁc chemical ﬁn-
gerprint. The type of the building construction and construction
materials are considered critical factors in mortality and epidemi-
ology of earthquake-related injuries. Survivors are frequently found
in conﬁned spaces of collapsed building structures. The retention
of these voids depends on the collapse mechanism {e.g., pancake,
lean-to, V-shaped [5]} and is much more likely in well-constructed,
reinforced concrete, steel-frame buildings than in masonry, brick,
or adobe constructions [6].
The presence of void spaces and the type of debris materials also
affect the dispersion and the air levels of potential volatile markers
of human presence. Here, a very important parameter is the debris
surface area-to-volume ratio (SA:V), as it governs the surface chem-
istry. High values of SA:V favor the adsorption of volatile species
on building materials and decrease their concentrations in void
spaces. Moreover, these losses can also be boosted by the pres-
ence of dust and powdered building materials covering the rubble
and buried victims. In particular, dust can notably suppress the emis-
sion of skin-borne species and thereby limit their applicability during
USaR operations.
Additional factors affecting the levels of VOCs in void spaces are
temperature and especially humidity. Relative humidity over 90%
induces condensation and formation of water ﬁlms and thereby trig-
gers wet chemistry. Thus, knowledge of the surface chemistry of
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Table 2
Predicted levels in void spaces (see text for detailed conditions), exemplary urban levels, possibilities of detection by portable instruments and classiﬁcation of potential volatile markers of human presence. The classiﬁcation
criteria are deﬁned in Section 6
A B C D E F
Compound CAS Predicted level at 3 m distance [ppb] Exemplary urban air levels Main urban sources Detection possibilities LOD, technique Class of marker
CO2
124-38-9
30 × 106 (b) 408 ppm (Dallas) [122]
(c) 390 ppm (Phenix) [123]
(d) 469 ppm (Wrocław) [124]
(e) 403–408 ppm (Portland) [125]
Vehicle emissions, (a) 0.25% optical sensor [126]
(b) 0.23% Solvatochromic probe [127]
A
NO
10102-43-9
7.7 (a) 24.5 ppb (Hong Kong) [128]
(b) 11.7 ppb (A Coruna) [129]
(c) 127/35 ppb (Seoul) [130]
Vehicle exhaust (a) 6 ppb chemiresistor (PEDOT:PSS/TiO2) [131]
(b) 5 ppb electrochemical (WO3/Pt) [132]
(c) 18 ppb chemiresistor (WO3/Cr2O3) [133]
(d) 3.6 ppb ICOS [134]
(e) 0.03 ppb lase QCL [135]
(f) 4 ppb electrochemical sensor [136]
C
CO
630-08-0
1350 (a) 1.6 ppm (Karachi) [137]
(b) 0.592 ppm (Hong Kong) [128]
(c) 1.7 ppm (Rio de Janeiro) [138]
(d) 0.53 ppm (London) [139]
(e) 1.2 ppm (Seul) [130]
Coal burning
Vehicular exhaust
Cigarette smoke
(a) 1 ppm chemiresistor (Ca-SnO2) [140]
(b) 1 ppm electrochemical sensor [141]
(c) 0.1 ppm controlled potential electrolysis [142]
(d) 4 ppb electrochemical sensor [136]
C
Ammonia
7664-41-7
1260 (a) 22 ppb (Santiago, Chile) [143]
(b) 24.7 ppb (Rome, Italy) [144]
(c) 5.5 ppb (New York, USA) [145]
(d) 8.2 ppb (Salzburg, Austria) [146]
(e) 9 ppb (Munich, Germany) [146]
Agriculture, vehicular exhaust (a) 0.014 ppb MCC-IMS [147]
(b) 50 ppm AIMS [148]
(c) 18 ppb chemiresistor (H2SO4 solution) [46]
(d) 50 ppb chemiresistor (MoO3) [149]
A
Acetone
67-64-1
435 (a) 18.6 ppb (Ottawa, Canada) [150]
(b) 5.4 ppb (Melbourne, Australia) [151]
(c) 1.1 ppb (Sao Paulo, Brazil) [152]
(d) 2.4 ppb (Quinzhou, China) [153]
(e) 13.5 ppb (average from towns) [154]
(f) 7 ppb (Beijing) [155]
(g) 1.45 ppb (Zurich, Switzerland) [156]
Solvents, oxidation of
NMHCs
(a) 0.02 ppb MCC-IMS [147]
(b) 14 ppb AIMS [157]
(c) 500 ppb AIMS [148]
(d) 20 ppb Si:WO3 chemiresistor [158]
(e) 120 ppb Pt-WO3 chemiresistor [159]
(f) 130 ppb optical spectroscopy [160]
(g) 170 ppb CTL (Mn3O4) [161]
A
2-Butanone
78–93-3
9.8 (a) 0.9 ppb (Ottawa) [150]
(b) 0.76 ppb (Quinzhou) [153]
(c) 1.35 ppb (average from towns) [154]
(d) 0.2 ppb (Zurich, Switzerland) [156]
(e) 0.5 ppb (Niterói City, Brazil) [162]
Industrial solvent (a) 11 ppb AIMS [157] B
2-Pentanone
107-87-9
3.2 (a) 8 ppb AIMS [157] B
5-Hepten-2-one, 6-methyl-
110-93-0
16.6 (a) 0.36 ppb (Rome) [163]
(b) 0.65 ppb (Milan) [163]
Plants (a) 0.7 ppb MCC-IMS [164] A
3-Buten-2-one
78–94-4
13.2 (a) 0.17 ppb (Hong Kong) [128]
(b) 0.43 ppb (Nashville) [165]
Oxidation of isoprene, vehicle
exhaust
B
2,3 Butanedione
431-03-8
20 Food, kitchen waste B
Acetaldehyde
75-07-0
98 (a) 9.4 ppb (Sao Paulo) [152]
(b) 2.4–45 ppb (Rio de Janeiro) [138]
(c) 8.0 ppb (Quinzhou) [153]
(d) 5.7 ppb (Beijing) [155]
(e) 3.6 ppb (Niterói City, Brazil) [162]
Ethanol fuel combustion,
oxidation of NMHCs
(a) 500 ppb AIMS [148]
(b) 110 ppb bio-sniffer [166]
(c) 0.15 ppb chemiresistor (ZnO) [167]
(d) 500 ppb CTL [168]
A
n-Propanal
123-38-6
15.4 (a) 0.4 ppb (Sao Paulo) [152]
(b) 0.35 ppb (Quinzhou) [153]
(c) 0.12 ppb (Zurich, Switzerland) [156]
(d) 0.83 ppb (Niterói City, Brazil) [162]
Disinfectant, kitchen waste,
vehicle exhaust
(a) 25 ppb AIMS [157]
(b) 0.15 ppb chemiresistor (ZnO) [167]
(c) 250 ppb CTL (ZrO2) [169]
A
2-Propenal
107-02-8
5.8 (a) 0.6 ppb (Sao Paulo) [152]
(b) 0.09 ppb (Zurich, Switzerland) [156]
Vehicle exhaust (a) 50 ppb AIMS [148] B
(continued on next page)
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Table 2 (continued)
A B C D E F
Compound CAS Predicted level at 3 m distance [ppb] Exemplary urban air levels Main urban sources Detection possibilities LOD, technique Class of marker
2-Propenal, 2-methyl
78–85-3
3.2 (a) 0.1 ppb (Hong Kong) [128]
(b) 0.24 ppb (Nashville) [165]
(c) 0.02 ppb (Zurich, Switzerland) [156]
Oxidation of isoprene, vehicle
exhaust
B
Propanal, 2-methyl-
78–84-2
1.3 Kitchen waste, vehicle exhaust C
Butanal, 2-methyl-
96-17-3
1.5 Kitchen waste C
Butanal, 3-methyl-
590-86-3
1.7 Kitchen waste C
n-Hexanal
66-25-1
26 (a) 1.2 ppb (Melbourne) [151]
(b) 0.35 ppb (Rome) [163]
Fuel combustion (a) 24 ppb AIMS [157]
(b) 0.3 ppb MCC-IMS [13]
A
n-Heptanal
111-71-7
7.1 (a) 0.4 ppb (Rome) [163] Fuel combustion, atmospheric
photooxidation of HCs,
kitchen waste
A
n-Octanal
124-13-0
8.2 (a) 0.48 ppb (Rome) [163] Fuel combustion, atmospheric
photooxidation of HCs,
kitchen waste
(a) 28 ppb AIMS [157]
(b) 0.1 ppb MCC-IMS [13]
A
n-Nonanal
124-19-6
13.6 (a) 1.4 ppb (Melbourne) [151]
(b) 1.2 ppb (average from towns) [154]
(c) 0.37 ppb (Rome) [163]
(d) 0.14 ppb (Niterói City, Brazil) [162]
Fuel combustion, atmospheric
photooxidation of HCs,
kitchen waste
(a) 0.3 ppb MCC-IMS [13] A
Isoprene
78–79-5
36 (a) 0.3 ppb (Seul) [170]
(b) 0.8 ppb (Karachi) [137]
(c) 0.13 ppb (Lille) [171]
(d) 0.34 ppb (Rome) [172]
(e) 0.252 ppb (Hong Kong) [128]
(f) 0.66 ppb (Guangzhou) [173]
(g) 0.41 ppb (Nashville) [165]
(h) 0.27 ppb (A Coruna) [129]
Plants, vehicular emissions (a) 0.003 ppb MCC-IMS [147]
(b) 36 ppb MIR [174]
A
1,3-Pentadiene, 2-methyl-, Z-
2787-45-3
0.3 C
1,3-Pentadiene, 2-methyl-, E-
926-54-5
0.2 C
2-Pentene, 2-methyl-
625-27-4
1.7 C
1-Heptene
592-76-7
0.23 C
n-Heptane
142-82-5
0.5 (a) 0.5 ppb (Seul) [170]
(b) 3.9 ppb (Karachi) [137]
(c) 9 ppb (Rio de Janeiro) [175]
(d) 0.05 ppb (Rome) [172]
(e) 0.56 ppb (Guangzhou) [173]
(f) 0.34 ppb (A Coruna) [129]
(f) 0.09 0.53 ppm (London) [139]
Petrol evaporation, vehicle
exhaust
C
1-Octene
111-66-0
0.5 C
n-Octane
111-65-9
1.5 (a) 0.3 ppb (Seul) [170]
(b) 1.1 ppb (Karachi) [137]
(c) 1.2 ppb (Rio de Janeiro) [175]
(d) 0.1 ppb (Lille) [171]
(e) 0.79 ppb (Guangzhou) [173]
(f) 0.3 ppb (A Coruna) [129]
(g) 0.04 ppb (London) [139]
Petrol evaporation, vehicle
exhaust
C
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Table 2 (continued)
A B C D E F
Compound CAS Predicted level at 3 m distance [ppb] Exemplary urban air levels Main urban sources Detection possibilities LOD, technique Class of marker
1-Nonene
124-11-8
0.57 C
n-Nonane
111-84-2
2.5 (a) 0.6 ppb (Seul) [170]
(b) 0.7 ppb (Karachi) [137]
(c) 2.1 ppb (Rio de Janeiro) [175]
(d) 0.95 ppb (average from towns) [154]
Petrol evaporation, vehicle
exhaust
C
Methanol
67-56-1
160 (a) 8 ppb (Barcelona) [176]
(b) 22 ppb (average from towns) [154]
(c) 14 ppb (Rio de Janeiro, Brazil) [177]
(d) 5.8 ppb (Osaka, Japan) [178]
(e) 1.8 ppb (Zurich, Switzerland) [156]
Solvents, biofuel evaporation (a) 100 ppm AIMS [148]
(b) 380 ppb CTL (nano-CdS) [179]
B
Ethanol
64-17-5
105 (a) 37 ppb (Melbourne) [151]
(b) 64 ppb (average from 50 studies) [154]
(c) 66.4 ppb (Rio de Janeiro, Brazil) [177]
(d) 8.2 ppb (Osaka, Japan) [178]
(e) 176.3 ppb (Sao Paulo, Brazil) [178]
(f) 6.6 ppb (Zurich, Switzerland) [156]
Solvents, biofuel evaporation, (a) 0.525 ppb MCC-IMS [147]
(b) 55 ppb AIMS [157]
(c) 300 ppb biochemical [180]
(d) 700 ppb CTL [181]
C
2-Propanol
67-63-0
69.6 (a) 7.4 ppb (Ottawa, Canada) [150]
(b) 7.2 ppb (Osaka, Japan) [178]
(c) 44.2 ppb (Sao Paulo, Brazil) [178]
Disinfectants, antifreeze,
biofuel evaporation
C
Dimethyl sulﬁde
75-18-3
9.0 (a) 0.37 ppb (Seul, Korea) [182] B
Allyl methyl sulﬁde
10152-76-8
0.5 C
Methyl propyl sulﬁde
3877-15-4
1.5 C
p-Cymene
99-87-6
0.8 Oxidation of α-pinene C
DL-Limonene
138-86-3
6.7 (a) 9.4 ppb (Rio de Janeiro) [175]
(b) 19.6 ppb (Melbourne) [151]
(c) 3.7 ppb (average from towns) [154]
Plants, wood emission, food,
kitchen waste
(a) 0.9 MCC-IMS [183] C
α-Pinene
80-56-8
0.65 (a) 2.4 ppb (Rio de Janeiro) [175]
(b) 6.2 ppb (Melbourne) [151]
(c) 0.2 ppb (Rome) [163]
(d) 0.21 ppb (Milan) [163]
(e) 0.19 (A Coruna) [129]
Plants, wood emission, food,
kitchen waste
(a) 0.9 MCC-IMS [183] C
Furan, 2-methyl-
534-22-5
6.8 B
Furan, 3-methyl-
930-27-8
0.3 (a) 0.05 ppb (USA) [184] Oxidation of isoprene, vehicle
exhaust
C
Furan, 2-pentyl-
3777-69-3
0.23 C
Acetonitrile
75-05-8
8.3 (a) 0.12 ppb (Sydney) [185] Biomass burning B
γ-Butyrolactone
96-48-0
5.8 Solvents B
Methyl acetate
79-20-9
1.6 (a) 0.06 ppb (Zurich, Switzerland) [156] Solvents, oxidation of MTBE
and TAME
B
Dimethyl selenide
593-79-3
0.14 C
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building materials can determine the applicability of markers of
human presence.
The interactions of VOCs forming the human scent with debris
materials have already received some attention. Several authors in-
vestigated the permeation of urine-borne volatiles through layers
of different buildingmaterials, such as concrete, brick, or quartz stone
[16,186,187]. Volatiles in the urine headspace were found to exhibit
a concentration proﬁlewith an initial peak related to urinating, which
was next washed out by the prevailing air currents. The inﬂuence
of debris materials on these proﬁles depended on their fundamen-
tal physicochemical properties. Brick was demonstrated to be amuch
less adsorptive material for urine-borne species than concrete. Al-
though concrete considerably reduced the observed levels of
compounds, it prolonged the presence of VOCs in the debris. Some
classes of compounds (i.e., furans, and sulfur-containing species)
showed weak interactions with the tested materials and were rel-
atively quickly removed from the surroundings of the urine samples.
Conversely, more polar analytes (e.g., ketones) were more inﬂu-
enced [14]. Predictably, the increase of molecular mass promoted
the interactions with debris and increased the residence times of
VOCs in void spaces [14]. Huo et al. [15] monitored species re-
leased by healthy volunteers closed in an environmental chamber
mimicking void space and permeating through a glass column
packed with different discs of building materials. The study involv-
ing whole-body emission demonstrated the permeation of CO2, NH3,
acetone, and isoprene through a collapsed building simulator.
Urban air is typically highly contaminated with numerous VOCs.
They predominantly stem from anthropogenic sources, such as
vehicle exhausts, solvents and fuel evaporation, fossil fuel combus-
tion, or emissions of liqueﬁed petroleum gas [126,137,170,172]. Their
levels may vary over relatively brief periods of time, show diurnal/
seasonal cycles, or exhibit spikes related to local temporal emissions.
Moreover, the proﬁles of urban VOCs differ from one country to
another due to differences in heating patterns, composition of vehicle
fuel, local regulations concerning VOC emissions, or climatic con-
ditions. This highly complex, variable phase becomes even more
complicated and harsh after massive collapse of buildings. Damaged
building structures, sewage systems, broken gas pipes, ﬁre and smoke
produce additional contaminants and/or toxic agents, which mix
with air ﬁlling the void spaces and human-borne volatiles [17,18].
In particular, released toxic agents might embrace polychlori-
nated biphenyls, hazardous metals, asbestos, various harmful gases
(e.g., hydrogen cyanide, hydrogen sulﬁde, halogenated gases, and
CO), detergents, acids and alkalis, ethylene glycol, propylene glycol,
phenol, and alcohols [18,188]. Furthermore, volatiles emitted by
rodents, insects or decomposing bodies can also complicate chem-
ical analysis at the disaster site and induce false positives [189]. All
these factors and confounders considerably affect the levels of the
human-speciﬁc volatiles in the voids of collapsed buildings andmake
their identiﬁcation and detection a really challenging task.
The complexity and the unpredictability of an entrapment en-
vironment, the variety of confounders and interactions, and ethical
restrictions also limit laboratory-based studies in this speciﬁc ﬁeld.
It is therefore very diﬃcult to model the behavior of the human-
speciﬁc chemical ﬁngerprint in the surroundings of the entrapped
person in reliable way, and predict the levels of its constituents.
However, knowledge of even approximate concentrations of po-
tential indicators of human presence would provide invaluable
beneﬁts for chemical analysis towards victim location, including:
(i) validation of potential markers against the possibility of their
detection in highly polluted air in the disaster environment;
(ii) selection of appropriate analytical instruments, which could
be used for the ﬁeld detection of entombed victims; and,
(iii) optimization of these techniques for the detection of human
markers in the disaster environment.
Asmentioned above, air ﬁlling void spaces in the collapsed build-
ings is highly contaminated with a complex chemical signature. In
particular, it is characterized by variable and unpredictable levels
of VOCs, which can interfere with human-speciﬁc chemical ﬁnger-
prints. Thus, debris air constitutes a background, against which
markers of human presence have to be identiﬁed and detected.
Despite these limitations, an effort wasmadewithin this work ten-
tatively to verify the preselectedmarkers against their typical urban
levels. Such a comparison couldhelp, for example, to excludemarkers
exhibiting emission rates that are too small to provide air levels able
to be reliably distinguished from the background. For this purpose,
a simple model of the dispersion of human-borne VOCs in debris
has been developed. In this model, an entrapped human is repre-
sented by a ball (i.e., a radially symmetric structure with a certain
radius R) emitting a constant stream j of VOCs. VOCs are assumed
to be inert species, which do not interact with the debris in the di-
saster environment (no losses/sinks of VOCs).Moreover, the transport
of VOCs in the voids of collapsed building is restricted only to dif-
fusion and diffusion coeﬃcients are postulated to be homogeneous
and constant. The results of the diffusion calculation are indepen-
dent of the speciﬁcally chosen radius of this ball (assuming, of course,
that the distance from the center of the ball is larger than radius R).
Appendix A gives detailed description of the applied model and
the calculations of tentative levels of human markers in the vicin-
ity of an entrapped victim. In general, the model predicts a VOC-
concentration decrease proportional to the inverse of the distance
from the victim. We stress that, although such a model is unreal-
istic and provides presumably overestimated concentrations of
species of interest, it can be used as the ﬁrst veriﬁcation tool for
the proposed preliminary markers. The exemplary calculations done
for the arbitrary chosen conditions: distance of 3 m from the en-
trapped person and a debris-to-air ratio 3:1 are presented in Table 2
and illustrated in Fig. 4. Hence, we assume that the volume of debris
is three times the volume of air, which is a reasonable assumption
[and can also easily be adapted, see formula (A.17) in Appendix A].
The realistic estimation of the latter factor poses an additional chal-
lenge, as it depends on the collapse pattern, which, in turn, is
determined by the type of the building construction and the build-
ing code [5,6]. Due to the shortage of information on this parameter,
it is futile to indicate its typical or most probable value. However,
it is reasonable to assume that it will be smaller for well-constructed,
reinforced concrete buildings. The values presented in Table 2 should
be treated rather as upper boundaries of possible marker levels. For
these particular conditions, the majority of compounds is ex-
pected to exhibit low-ppb levels. More speciﬁcally, concentrations
of 19 species (40%) might be spread around 1 ppb and levels of
further 13 (28%) should not exceed 10 ppb. Only seven com-
pounds (CO2, CO, ammonia, acetone, methanol, ethanol, and
acetaldehyde) could produce levels higher than 100 ppb in the vi-
cinity of survivors.
These values can next be compared to the typical urban con-
centrations of species of interest. For this purpose, an extensive
literature search was done. Effort was made to select data re-
ported for cities from different countries and continents to include
region/continent dependent differences in concentrations. We stress
that, for several compounds, the urban/indoor air data are diﬃ-
cult to obtain, due to their low toxicity, ultra-low levels and,
consequently, lack of regulations concerning their emissions. The
typical urban air levels of markers under scrutiny have been listed
in Table 2 and are shown in Fig. 4.
In general, we believe that valuable information can be ex-
tracted from the juxtaposition of these data. First, levels of several
tentative indicators can be too low to be distinguished from the back-
ground in the void spaces of collapsed buildings. For example,
emission of CO from the human body can produce levels compa-
rable to those usual in urban air. Bearing in mind that CO levels
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exhibit diurnal and seasonal variability, it can be very diﬃcult to
separate urban and human-borne components of CO levels during
a chemical analysis in the ﬁeld. Moreover, concentrations of CO can
change considerably during the USaR operation as a result of inci-
dental hazards or ﬁres [18,19]. The same holds true for methanol
and ethanol. Although both these alcohols show relatively high abun-
dances in the human chemical signature, their urban levels are also
high. The high urban background stems from the increasing use of
alcohols as alternative energy sources, replacing gasoline and related
emission of unburned fuel, or their evaporation from leaking tanks
[177]. Overall, the suitability of several constituents from the pro-
posed set can be reduced by high and variable urban air levels.
Bearing in mind all the above problems and confounders, it is
diﬃcult to establish a clear criterion, which would exclude markers
being too affected by urban air to be applied to detect entrapped
victims. Nevertheless, a suﬃciently high difference between back-
ground levels and human-borne levels in debris air seems to be a
reasonable discriminant. Within this review, void concentrations at
least 10 times higher than the urban-air background were recog-
nized as a threshold. Several species from the original set failed to
fulﬁll this criterion (e.g., CO, ethanol, 2-propanol, NO, DL-limonene,
n-nonane, n-octane, α-pinene, and n-heptane). Interestingly, apart
from DL-limonene and α-pinene, species from this group are typical
vehicle exhausts, or fuel vapors. This ﬁnding makes vehicle-related
pollution one of the main confounders hindering application of the
human chemical ﬁngerprint during USaR operations.
6. Analytical instrumentation for ﬁeld detection of VOCs
The laboratory-based analytical instruments commonly used to
determine and to track volatile species forming the human-
speciﬁc chemical pattern are inherently large in size and expensive,
demand laborious and time-consuming sample-preparationmethods,
and require well-trained, experienced operators. These attributes
place signiﬁcant limitations on their routine use in ﬁeld condi-
tions in general and the disaster environment in particular. Here,
simple-in-use (“yes/no” response), rapid, hand-held, low-energy and
simultaneously sensitive screening instruments are desirable. A
number of technologies could meet these requirements.
Recent rapid progress in electronic sensor technology has stimu-
lated the development of devices known as electronic noses (e-noses)
[190], which are arrays of different non-selective sensors capable
of detecting and discriminating a wide diversity of chemical species.
Strictly speaking, their responses are not correlated to one specif-
ic compound, but rather to the whole chemical ﬁngerprint. Thus,
e-noses discriminate different VOC proﬁles using qualitative or semi-
quantitative information. The versatile capabilities of e-noses stem
from the variety of sensors available for selection for sensor arrays
Fig. 4. Exemplary chemical signature of entrapped person predicted for a point located 3 m from a survivor and debris-to-air ratio 3:1. Red bars indicate mean urban air
levels of compounds of interest.
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(i.e., conducting-polymer, metal-oxide, optical, and electrochemi-
cal) and the abilities of manufacturers to produce customized, low-
cost, multi-use devices for particular applications [190–193].
However, a key prerequisite for the success of e-nose devices in a
particular application is knowledge of the chemical pattern of in-
terest, which can only be provided by more sophisticated analytical
techniques. If successful, sensor arrays may revolutionize USaR op-
erations, when built into robust and small instruments. Once
installed, e.g., on borescopes, they could penetrate the collapsed
structures and screen their interiors for volatile chemical signs of
life. Despite encouraging facilities, sensor arrays suffer from several
disadvantages, such as temperature-dependent stability, or humid-
ity effects.
Another promising technique is ion-mobility spectrometry (IMS)
separating volatiles on the basis of differences in their migration
speed in an inert buffer gas under the inﬂuence of an electric ﬁeld
[194]. Recent rapid advances in IMS resulted in the development
of numerous sub-techniques exploiting different strengths and forms
of the electric ﬁelds [e.g., linear drift tube IMS (DTIMS), travelling
wave IMS (TWIMS), aspiration IMS (AIMS), or ﬁeld-asymmetric IMS
(FAIMS)], or combining IMS with other techniques [e.g. GC multi-
capillary column IMS (MCC-IMS)]. The IMS instruments can be
miniaturized, measure rapidly, have low energy consumption, and
are very sensitive. Moreover, these techniques have already been
successfully applied for the ﬁeld detection and identiﬁcation of
chemical warfare agents (CWAs), or toxic industrial chemicals (TICs),
and the expertise and know-how gained within these applica-
tions could be transferred into the “search and rescue” science,
notably accelerating the pace of investigations.
Fast GC, combined with MS detection also exhibits a consider-
able potential for USaR operations. Short analysis time (several
minutes) and progressive miniaturization render this technique a
possible tool for locating entrapped victims. Fast GC-MS instru-
ments can be ﬁeld-portable [195,196] and, in combinationwith some
pre-concentrationmethods [e.g., solid-phasemicroextraction (SPME)]
could provide the detection of the majority of volatiles under scru-
tiny. Nevertheless, their weight (10–20 kg) still hinders their
applicability in searching large disaster areas.
However, the successful employment of the above techniques
for locating entrapped victims is determined by their analytical limi-
tations. Here the limit of detection (LOD) can be regarded as a basic
factor inﬂuencing the selection of the optimal technique. Table 2
lists exemplary LODs of different sensor-based or IMS-based in-
struments reported for some of compounds of interest. We stress
that some of these analytical tools are still at the early phase of the
development and should be considered as prototypes. Several con-
clusions can be distilled from this comparison. First, the detection
of many potential volatile signs of life can pose a challenge due to
their ultra-low concentrations and the unsatisfactory capabilities
of the available ﬁeld techniques. Nevertheless, we expect rapid pro-
gress in analytical chemistry instrumentation to solve this problem
in the future. In this context, an interesting technique is MCC-IMS.
Although this technique is strictly speaking not hand-held and real-
time, and can impose operational problems for inexperienced users,
it offers LODs that are adequate for the detection of many com-
pounds under scrutiny. Indeed, recently MCC-IMSwas demonstrated
to be capable of detecting some constituents of human scent [13].
7. Classiﬁcation of potential markers of human presence
An ideal marker of human presence should be omnipresent, vol-
atile, relatively non-reactive, continuously emitted by the human
body and present at relatively high concentrations in the proxim-
ity of an entrapped victim. In this spirit, we propose the classiﬁcation
of potential indicators of human presence preselected within this
review into three subsets:
• Subset A comprises predominantly endogenous species exhib-
iting high emission rates from the human body, which can
produce debris concentrations detectable by currently avail-
able, portable ﬁeld analyzers and are clearly distinguishable from
urban background levels. This group represents the most prom-
ising markers.
• Subset B contains volatiles of different (frequently unknown)
origins with tentatively predicted debris levels being at least
10-fold higher than the expected background levels, but too low
to be reliably detected by current portable techniques.
• Subset C incorporates volatiles stemming from sources that can
be suppressed during the entrapment, or species with poten-
tial debris levels diﬃcult to separate from the urban background.
Table 2 shows the proposed classiﬁcation of particular species
of interest. Following this classiﬁcation, CO2, ammonia, acetone,
6-methyl-5-hepten-2-one, isoprene, n-propanal, n-hexanal,
n-heptanal, n-octanal, n-nonanal, and acetaldehyde constitute class
A, and are thereby the strongest candidates for markers of human
presence. The potential of class A species is also supported by some
of them having already been indicated as promising human indi-
cators by several early studies [13–15].
8. Conclusions
Themain goals of this reviewwere to create a database of human-
borne volatiles having high potential as markers of human presence,
which could be used for early location of entrapped victims during
rescue operations, and to estimate their emission rates from the
human body on the basis of existing literature data.
Altogether, 47 compounds were pre-selected using skin emis-
sion and quantitative exhaled breath data. They belong to several
chemical classes; however, aldehydes and hydrocarbons are themost
numerous. We stress that these species may originate from several
distinct sources and their production is still far from being com-
pletely understood.
Due to the nature of this speciﬁc ﬁeld, and ethical and meth-
odological restrictions, the prediction of ﬂuxes of these species and
their concentrations in the voids of collapsed buildings poses con-
siderable challenges and problems. In particular, unpredictable and
variable conditions in the entrapment environment, shortage of
quantitative data on VOC emissions by the human body, or poorly
known interactions of VOCs with debris materials affect efforts
towards this goal. In this context, the emission rates that we cal-
culated should be treated as tentative and the predicted
concentrations in void spaces as approximate, indicating only the
order of magnitude of the expected levels in real situations (e.g.,
low ppb, ppt).
We believe that valuable information can be distilled from the
data we presented. First, optimal ﬁeld analytical techniques can be
selectedon thebasis of thephysicochemical characteristics ofmarkers
and their approximate levels in conﬁned spaces. These techniques
can be further improved to provide an optimal response at the di-
saster site (targeted analysis). Moreover, species from the proposed
set can be veriﬁed by lowering the value of those, which produce
a signal too small to be reliably separated from the background.
To sum up, the set of potential markers of the human presence
preselected within this review should be considered as an initial
database of species to be veriﬁed during ﬁeld studies. Within this
context, a major focus lies on the investigations of interactions of
volatiles of interest with building materials and other adsorbents
in the disaster environment, such as clothing, dust, or soil. Further
efforts will need to take into account disaster-related emission of
species as well as different conditions such as, e.g., temperature and
humidity affecting the surface chemistry. Thus, we expect that the
VOC database proposed here will be further complemented and
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veriﬁed. However, the success of chemical analysis toward the de-
tection of humans will primarily depend on the availability of
analytical technologies for the rapid, continuous, ﬁeld detection of
volatiles as signs of life. Although a number of techniques show a
huge potential in this context, their applicability has to be veriﬁed
in harsh, highly contaminated, and toxic disaster environments. In
this sense, we recognize that data and considerations included in
this review will guide future investigations in this exciting ﬁeld.
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Appendix A: On decrease of exhaled VOC concentrations
We use the following notation: t time variable, x space coor-
dinates, C t x,( ) concentration of a VOC, V volume, S surface of V ,
∂V boundary of V F, ﬂux, n normal vector.
For the following, compare Evans (Section 2.3) [197].
The change of mass in a volume V is given by the ﬂux through
the surface of V plus the net production in V . Thus the mass balance
for a ﬁxed volume V then reads
d
dt
C t x dV F ndS f t x dV
V V V
, ,( ) = − ⋅ + ( )∫ ∫ ∫∂ (A.1)
where f is the production rate in V . Using Stokes’ theorem (Gauss’s
divergence theorem) which states:
F ndS F dV
V V
⋅ = ∇⋅( )
∂∫ ∫ (A.2)
where ∇⋅ =F Fdiv , and we arrive at:
d
dt
C t x dV F dV f t x dV
V V V
, , .( ) = − ∇⋅( ) + ( )∫ ∫ ∫ (A.3)
By Fick’s law the ﬂux F is proportional (diffusion constant a > 0)
to the gradient of the concentration ∇ ( )C t x, .
F a C t x= − ∇ ( ), . (A.4)
We arrive at
C t x a C t x f t xt , , , .( ) = ∇⋅ ∇ ( )( ) + ( ) (A.5)
Remark: up to this point the derivation is completely general. We
make now the following assumptions:
Assumption 1: a is homogeneous and constant
Assumption 2: A human is modeled by a ball with radius R
emitting a constant stream of a VOC (e.g., nmol/min) of the form
f t x f x
J
R
xBR, ,( ) = ( ) = ( )( )34 3 0

π
χ (A.6)
where χBR 0( ) denotes the characteristic function of a ball with radius
R at x = 0 and J the emitted stream. Here f is chosen such that
there is constant production within the ball which totals to J. Note
that the speciﬁc form of f will not affect the concentration outside
the ball as long as it is radially symmetric.
Then we have
C t x a C t x f xt , , .( ) = ( ) + ( )Δ (A.7)
Now we consider stationary solutions
0 = ( )+ ( )a C t x f xΔ , . (A.8)
A special solution Cs of the non-homogeneous Equation (A.8) is
given by
C x
J
Ra
x
R
x R
R
x
x R
s ( ) =
−
⎛
⎝⎜
⎞
⎠⎟ ≤
≥
⎧
⎨
⎪⎪
⎩
⎪⎪
9
4
1
2
1
3
1
3
2
2
π
, ,
, .
(A.9)
If we consider an initial concentration
C x g x0,( ) = ( ) (A.10)
the general solution of Equation (A.7) is then given by
C t x C x g x g x g x C xs t s, , ,( ) = ( ) + ∗( )( ) ( ) = ( ) − ( )Φ   (A.11)
where
Φt
x
atx
at
e( ) = ( )
−1
4
3 2
4
2
π
(A.12)
denotes the fundamental solution of the heat equation and * denotes
convolution.
Note that the convergence to the equilibrium concentration can
be estimated by
Φt g
at
g∗ ≤ ( )∞ ∞ 
1
4
3 2
π
(A.13)
and in the special case g ≡ 0, that is g Cs= − , we have


g C
J
aR
s∞ ∞= =
3
4π
. (A.14)
Summary
The stationary solution reads
C x
J
a x
x Rs ( ) = ≥34
1
π
, . (A.15)
An example: J = 12 nmol min, a ≈ =0 1 0 00062 2. sec . mincm m
yields
C x nmol m
x
x Rs ( ) = [ ] ≥4775 12 , . (A.16)
At a distance of 10 m this yields 477.5 nmol/m3 or 0.4775 nmol/l.
Remark 1: Inert debris will raise the concentration and can be
taken into account at the ﬁrst attempt by scaling the distance x
by a factor ρ1 3, 0 10 0< = −( ) ≤ρ V V Vf , where V0 is the volume in the
absence of debris and Vf is the volume ﬁlled by debris.
C x
J
a x
x Rs ( ) = ≥34
1 1
1 3

π ρ
, . (A.17)
If we assume that the volume of debris is three times the volume
of air then
V V V V V Vdebris air f debris air0
1 3
3
1 4 1
: , : .= + =
= ≈
=
This yields andρ ρ 1 59. .
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Remark 2: In our simplemodel, we assumed that diffusion is con-
stant and homogenous that allowed for an analytical solution of the
problem. Other geometries can be incorporated and computed
numerically.
Remark 3: Initially, when a human is suddenly entrapped, the
surroundingwill show the background level of VOCs. As he/she emits
VOCs, these VOCs will diffuse into his/her surroundings and, after
a certain time, a constant distribution of VOCs will be established
according to formula (A.17). The concentration of these VOCs is pro-
portional to the stream J he/she emits andwill decrease proportional
to the inverse of the distance x from him/her and is also inverse
proportional to a where a is the diffusion constant.
If there are two or three persons close together within a ball of
radius R, then one can simply multiply the stream J by a factor of
2 or 3.
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